Fig. 1From: Lifetime expectancy and quality-adjusted life-year in Alzheimer’s disease with and without cerebrovascular disease: effects of nursing home replacement and donepezil administration – a retrospective analysis in the Tajiri ProjectPeriod of DNP use and QALY for each AD groupBack to article page